Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ali Jalali. (2024) Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies. Expert Review of Pharmacoeconomics & Outcomes Research 24:5, pages 599-611.
Read now
Read now
Yuri A. Maricich, Edward V. Nunes, Aimee N. C. Campbell, Jeffrey D. Botbyl & Hilary F. Luderer. (2022) Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study. Substance Abuse 43:1, pages 937-942.
Read now
Read now
Fulton F. Velez, Danmeng Huang, Lorie Mody & Daniel C. Malone. (2022) Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder. Expert Review of Pharmacoeconomics & Outcomes Research 22:4, pages 599-607.
Read now
Read now
Fulton F. Velez, Charles Ruetsch & Yuri Maricich. (2021) Evidence of long-term real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic. Expert Review of Pharmacoeconomics & Outcomes Research 21:4, pages 519-520.
Read now
Read now
Fulton F. Velez, Hilary F. Luderer, Robert Gerwien, Benjamin Parcher, Dylan Mezzio & Daniel C. Malone. (2021) Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Postgraduate Medicine 133:4, pages 421-427.
Read now
Read now
Yuri A. Maricich, Xiaorui Xiong, Robert Gerwien, Alice Kuo, Fulton Velez, Bruce Imbert, Keely Boyer, Hilary F. Luderer, Stephen Braun & Karren Williams. (2021) Real-world evidence for a prescription digital therapeutic to treat opioid use disorder. Current Medical Research and Opinion 37:2, pages 175-183.
Read now
Read now
Articles from other publishers (18)
Edmund W. J. Lee, Huanyu Bao, Yongda S. Wu, Man Ping Wang, Yi Jie Wong & K. Viswanath. (2024) Examining health apps and wearable use in improving physical and mental well-being across U.S., China, and Singapore. Scientific Reports 14:1.
Crossref
Crossref
Emily Peake, Ian Miller, Jessica Flannery, Lang Chen, Jessica Lake & Aarthi Padmanabhan. (2024) Preliminary Efficacy of a Digital Intervention for Adolescent Depression: Randomized Controlled Trial. Journal of Medical Internet Research 26, pages e48467.
Crossref
Crossref
Zack Biskupiak, Victor Vinh Ha, Aarushi Rohaj & Grzegorz Bulaj. (2024) Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases. Journal of Clinical Medicine 13:2, pages 403.
Crossref
Crossref
Ginnie Sawyer-Morris, Judith A. Wilde, Todd Molfenter & Faye Taxman. (2023) Use of Digital Health and Digital Therapeutics to Treat SUD in Criminal Justice Settings: a Review. Current Addiction Reports 11:1, pages 149-162.
Crossref
Crossref
Emily Grayek, Tamar Krishnamurti, Lydia Hu, Olivia Babich, Katherine Warren & Baruch Fischhoff. (2023) Collection and Analysis of Adherence Information for Software as a Medical Device Clinical Trials: Systematic Review. JMIR mHealth and uHealth 11, pages e46237.
Crossref
Crossref
Aaron Richterman, Fatemeh Ghadimi, Anne M. Teitelman, Kevin Moore, Trisha Acri, Hannah North, Kasandra Lopez, Vuthy Ou, Amelia E. Van Pelt & Florence Momplaisir. (2023) Acceptability and Feasibility of a Mobile Phone Application to Support HIV Pre-exposure Prophylaxis Among Women with Opioid Use Disorder. AIDS and Behavior 27:10, pages 3460-3467.
Crossref
Crossref
Anthony DeFulio, Hayley D. Brown, Rosemarie M. Davidson, Sean D. Regnier, Navdeep Kang & Melissa Ehart. (2022) Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone-Based Contingency Management Intervention for Buprenorphine Adherence. Behavior Analysis in Practice 16:2, pages 450-458.
Crossref
Crossref
Michael Curtis, Anna L. Wilkinson, Paul Dietze, Ashleigh C. Stewart, Stuart A. Kinner, Rebecca J. Winter, Campbell Aitken, Shelley J. Walker, Reece D. Cossar, Tony Butler & Mark Stoové. (2023) Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study. Harm Reduction Journal 20:1.
Crossref
Crossref
Anthony DeFulio. (2022) Dissemination of Contingency Management for the Treatment of Opioid Use Disorder. Perspectives on Behavior Science 46:1, pages 35-49.
Crossref
Crossref
Sanya Virani & Patricia Ryan Recupero. 2023. Technology-Assisted Interventions for Substance Use Disorders. Technology-Assisted Interventions for Substance Use Disorders
107
113
.
Philip D. HarveyColin A. DeppAlbert A. RizzoGregory P. StraussDavid SpelberLinda L. CarpenterNed H. KalinJohn H. KrystalWilliam M. McDonaldCharles B. NemeroffCarolyn I. RodriguezAlik S. WidgeJohn Torous. (2022) Technology and Mental Health: State of the Art for Assessment and Treatment. American Journal of Psychiatry 179:12, pages 897-914.
Crossref
Crossref
Fulton F. Velez, Kathryn P. Anastassopoulos, Samuel Colman, Neel Shah, Laura Kauffman, Sean M. Murphy, Charles Ruetsch & Yuri A. Maricich. (2022) Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic. Advances in Therapy 39:9, pages 4131-4145.
Crossref
Crossref
Michael Hsu, Bianca Martin, Saeed Ahmed, John Torous & Joji Suzuki. (2022) Smartphone Ownership, Smartphone Utilization, and Interest in Using Mental Health Apps to Address Substance Use Disorders: Literature Review and Cross-sectional Survey Study Across Two Sites. JMIR Formative Research 6:7, pages e38684.
Crossref
Crossref
Ieuan Clay, Francesca Cormack, Szymon Fedor, Luca Foschini, Giovanni Gentile, Chris van Hoof, Priya Kumar, Florian Lipsmeier, Akane Sano, Benjamin Smarr, Benjamin Vandendriessche & Valeria De Luca. (2022) Measuring Health-Related Quality of Life With Multimodal Data: Viewpoint. Journal of Medical Internet Research 24:5, pages e35951.
Crossref
Crossref
Xiaojun Wu, Jiang Du, Haifeng Jiang & Min Zhao. (2021) Application of Digital Medicine in Addiction. Journal of Shanghai Jiaotong University (Science) 27:2, pages 144-152.
Crossref
Crossref
Hilary Luderer, Lisa Chiodo, Amanda Wilson, Christina Brezing, Suky Martinez, Xiaorui Xiong, Robert Gerwien, Bruce Imbert, Mark Deeg, Yuri Maricich & Aimee Campbell. (2022) Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial. JMIR Research Protocols 11:1, pages e32759.
Crossref
Crossref
Assaf Gottlieb, Christine Bakos-Block, James R. Langabeer & Tiffany Champagne-Langabeer. (2022) Sociodemographic and Clinical Characteristics Associated with Improvements in Quality of Life for Participants with Opioid Use Disorder. Healthcare 10:1, pages 167.
Crossref
Crossref
Hannah Moshontz, Alejandra J Colmenares, Gaylen E Fronk, Sarah J Sant'Ana, Kendra Wyant, Susan E Wanta, Adam Maus, David H Gustafson Jr, Dhavan Shah & John J Curtin. (2021) Prospective Prediction of Lapses in Opioid Use Disorder: Protocol for a Personal Sensing Study. JMIR Research Protocols 10:12, pages e29563.
Crossref
Crossref